{"transactions":[{"id":4635451,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:43:49.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":3662,"price":3.14,"value":11498.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026."}],"balance_after":75612,"source":{"system":"sec-edgar","filing":"0001470831-26-000925","document":"wk-form4_1790973827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000925/wk-form4_1790973827.xml","form_type":"4"}},{"id":4635452,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:43:42.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":4618,"price":3.14,"value":14500.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026."}],"balance_after":79471,"source":{"system":"sec-edgar","filing":"0001470831-26-000924","document":"wk-form4_1790973819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000924/wk-form4_1790973819.xml","form_type":"4"}},{"id":4623278,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-21T20:24:49.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":3.39,"value":9407.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":382323,"source":{"system":"sec-edgar","filing":"0001470831-26-000895","document":"wk-form4_1790022287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000895/wk-form4_1790022287.xml","form_type":"4"}},{"id":4623277,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-21T20:24:49.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023."}],"balance_after":385098,"source":{"system":"sec-edgar","filing":"0001470831-26-000895","document":"wk-form4_1790022287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000895/wk-form4_1790022287.xml","form_type":"4"}},{"id":710497,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:33:49.000Z","date":"2026-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7397,"price":4.06,"value":30031.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":372406,"source":{"system":"sec-edgar","filing":"0001470831-26-000705","document":"wk-form4_1783974826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000705/wk-form4_1783974826.xml","form_type":"4"}},{"id":710496,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:33:49.000Z","date":"2026-07-10","kind":"exercise","planned":false,"acquired":true,"shares":15325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023."}],"balance_after":379803,"source":{"system":"sec-edgar","filing":"0001470831-26-000705","document":"wk-form4_1783974826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000705/wk-form4_1783974826.xml","form_type":"4"}},{"id":717131,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:04:40.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2650,"price":4.34,"value":11501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2026."}],"balance_after":71950,"source":{"system":"sec-edgar","filing":"0001470831-26-000688","document":"wk-form4_1783022665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000688/wk-form4_1783022665.xml","form_type":"4"}},{"id":717130,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:04:39.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3341,"price":4.34,"value":14499.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2026."}],"balance_after":74853,"source":{"system":"sec-edgar","filing":"0001470831-26-000689","document":"wk-form4_1783022677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000689/wk-form4_1783022677.xml","form_type":"4"}},{"id":725453,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-27T00:33:06.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000673","document":"wk-form4_1782520384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000147083126000673/wk-form4_1782520384.xml","form_type":"4"}},{"id":725279,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":26666,"kind":"person","name":"Hoerter Steven L.","position":1,"cik":"0001533451","reported_name":"Hoerter Steven L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-27T00:26:57.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000670","document":"wk-form4_1782520015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533451/000147083126000670/wk-form4_1782520015.xml","form_type":"4"}},{"id":725220,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35088,"kind":"person","name":"Koppikar Utpal","position":1,"cik":"0001742696","reported_name":"Koppikar Utpal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:31:14.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000667","document":"wk-form4_1782505872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000667/wk-form4_1782505872.xml","form_type":"4"}},{"id":725219,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:30:22.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000665","document":"wk-form4_1782505819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000665/wk-form4_1782505819.xml","form_type":"4"}},{"id":725218,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35087,"kind":"person","name":"Cooper Ronald Harold Wilfred","position":1,"cik":"0001676880","reported_name":"Cooper Ronald Harold Wilfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:29:27.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000663","document":"wk-form4_1782505765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000663/wk-form4_1782505765.xml","form_type":"4"}},{"id":725217,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35086,"kind":"person","name":"Bessen Laura","position":1,"cik":"0001926815","reported_name":"Bessen Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:28:14.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000661","document":"wk-form4_1782505691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000661/wk-form4_1782505691.xml","form_type":"4"}},{"id":725714,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35222,"kind":"person","name":"Fawell Stephen","position":1,"cik":"0002033387","reported_name":"Fawell Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:27:23.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000659","document":"wk-form4_1782505640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033387/000147083126000659/wk-form4_1782505640.xml","form_type":"4"}},{"id":725213,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:25:44.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000657","document":"wk-form4_1782505541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000657/wk-form4_1782505541.xml","form_type":"4"}},{"id":749131,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:14:41.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":1070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":1070},"source":{"system":"sec-edgar","filing":"0001470831-26-000504","document":"wk-form4_1780604078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000504/wk-form4_1780604078.xml","form_type":"4"}},{"id":749130,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T20:14:41.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":1070,"price":2.11,"value":2257.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise."}],"balance_after":69300,"source":{"system":"sec-edgar","filing":"0001470831-26-000504","document":"wk-form4_1780604078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000504/wk-form4_1780604078.xml","form_type":"4"}},{"id":815528,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T14:45:54.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":4259,"price":2.7,"value":11499.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026."}],"balance_after":68230,"source":{"system":"sec-edgar","filing":"0001470831-26-000346","document":"wk-form4_1775227552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000346/wk-form4_1775227552.xml","form_type":"4"}},{"id":815527,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T14:45:44.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":5370,"price":2.7,"value":14499.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026."}],"balance_after":71512,"source":{"system":"sec-edgar","filing":"0001470831-26-000345","document":"wk-form4_1775227541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000345/wk-form4_1775227541.xml","form_type":"4"}},{"id":895663,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:05:05.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7269,"price":1.89,"value":13738.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":299881,"source":{"system":"sec-edgar","filing":"0001470831-26-000178","document":"wk-form4_1771452301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000178/wk-form4_1771452301.xml","form_type":"4"}},{"id":895662,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:05:05.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":20950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":307150,"source":{"system":"sec-edgar","filing":"0001470831-26-000178","document":"wk-form4_1771452301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000178/wk-form4_1771452301.xml","form_type":"4"}},{"id":895661,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:05:05.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1735,"price":1.89,"value":3279.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":307150,"source":{"system":"sec-edgar","filing":"0001470831-26-000178","document":"wk-form4_1771452301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000178/wk-form4_1771452301.xml","form_type":"4"}},{"id":895660,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:05:05.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":308885,"source":{"system":"sec-edgar","filing":"0001470831-26-000178","document":"wk-form4_1771452301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000178/wk-form4_1771452301.xml","form_type":"4"}},{"id":895659,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:05:05.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 100,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 100,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":308885,"source":{"system":"sec-edgar","filing":"0001470831-26-000178","document":"wk-form4_1771452301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000178/wk-form4_1771452301.xml","form_type":"4"}},{"id":895836,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:58.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9057,"price":1.89,"value":17117.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":1074934,"source":{"system":"sec-edgar","filing":"0001470831-26-000177","document":"wk-form4_1771452294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000147083126000177/wk-form4_1771452294.xml","form_type":"4"}},{"id":895835,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:58.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 15, 2024 and February 18, 2025."}],"balance_after":1083991,"source":{"system":"sec-edgar","filing":"0001470831-26-000177","document":"wk-form4_1771452294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000147083126000177/wk-form4_1771452294.xml","form_type":"4"}},{"id":895834,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:58.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":39154,"price":1.89,"value":74001.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":1083991,"source":{"system":"sec-edgar","filing":"0001470831-26-000177","document":"wk-form4_1771452294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000147083126000177/wk-form4_1771452294.xml","form_type":"4"}},{"id":895833,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:58.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":81725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 15, 2024 and February 18, 2025."}],"balance_after":1123145,"source":{"system":"sec-edgar","filing":"0001470831-26-000177","document":"wk-form4_1771452294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000147083126000177/wk-form4_1771452294.xml","form_type":"4"}},{"id":895832,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:58.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 350,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 350,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":1123145,"source":{"system":"sec-edgar","filing":"0001470831-26-000177","document":"wk-form4_1771452294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000147083126000177/wk-form4_1771452294.xml","form_type":"4"}},{"id":895877,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":16579,"price":1.89,"value":31334.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":379803,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":895876,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":30950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 14, 2024 and February 18, 2025."}],"balance_after":396382,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":895875,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":396382,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":897367,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65931,"kind":"person","name":"Mossler Mark","position":1,"cik":"0001992219","reported_name":"Mossler Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:38.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":3268,"price":1.89,"value":6176.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":71916,"source":{"system":"sec-edgar","filing":"0001470831-26-000174","document":"wk-form4_1771452272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1992219/000147083126000174/wk-form4_1771452272.xml","form_type":"4"}},{"id":897366,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65931,"kind":"person","name":"Mossler Mark","position":1,"cik":"0001992219","reported_name":"Mossler Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:38.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":9420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on April 10, 2024 and February 18, 2025."}],"balance_after":75184,"source":{"system":"sec-edgar","filing":"0001470831-26-000174","document":"wk-form4_1771452272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1992219/000147083126000174/wk-form4_1771452272.xml","form_type":"4"}},{"id":897365,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65931,"kind":"person","name":"Mossler Mark","position":1,"cik":"0001992219","reported_name":"Mossler Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:38.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":56980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 28,490 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 28,490 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":75184,"source":{"system":"sec-edgar","filing":"0001470831-26-000174","document":"wk-form4_1771452272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992219/000147083126000174/wk-form4_1771452272.xml","form_type":"4"}},{"id":898512,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:18.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7269,"price":1.89,"value":13738.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":298801,"source":{"system":"sec-edgar","filing":"0001470831-26-000180","document":"wk-form4_1771452315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000147083126000180/wk-form4_1771452315.xml","form_type":"4"}},{"id":898511,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:18.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":20950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":306070,"source":{"system":"sec-edgar","filing":"0001470831-26-000180","document":"wk-form4_1771452315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000147083126000180/wk-form4_1771452315.xml","form_type":"4"}},{"id":898510,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:18.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1735,"price":1.89,"value":3279.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":306070,"source":{"system":"sec-edgar","filing":"0001470831-26-000180","document":"wk-form4_1771452315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000147083126000180/wk-form4_1771452315.xml","form_type":"4"}},{"id":898509,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:18.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":307805,"source":{"system":"sec-edgar","filing":"0001470831-26-000180","document":"wk-form4_1771452315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000147083126000180/wk-form4_1771452315.xml","form_type":"4"}},{"id":898508,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:18.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 100,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 100,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":307805,"source":{"system":"sec-edgar","filing":"0001470831-26-000180","document":"wk-form4_1771452315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000147083126000180/wk-form4_1771452315.xml","form_type":"4"}},{"id":897479,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2446,"price":1.89,"value":4622.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":336910,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":897478,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of RSUs. The grant of RSUs was initially reported in Table I of the Forms 4 filed by the Reporting Person on February 18, 2025."}],"balance_after":339356,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":897477,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":339356,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":897363,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":15381,"price":1.89,"value":29070.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":385098,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897362,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":30950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":400479,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897361,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1863,"price":1.89,"value":3521.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":400479,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897360,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":402342,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897359,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":402342,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":936818,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T21:27:58.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":2.22,"value":22200.0,"ownership":{"direct":true},"balance_after":156382,"source":{"system":"sec-edgar","filing":"0001470831-26-000045","document":"wk-form4_1768598875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000045/wk-form4_1768598875.xml","form_type":"4"}},{"id":949898,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T21:10:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5958,"price":1.93,"value":11498.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026."}],"balance_after":146532,"source":{"system":"sec-edgar","filing":"0001470831-26-000009","document":"wk-form4_1767647442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000009/wk-form4_1767647442.xml","form_type":"4"}},{"id":949897,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T21:10:26.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7513,"price":1.93,"value":14500.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026."}],"balance_after":66142,"source":{"system":"sec-edgar","filing":"0001470831-26-000008","document":"wk-form4_1767647408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000008/wk-form4_1767647408.xml","form_type":"4"}},{"id":1011458,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-30T16:30:04.000Z","date":"2025-10-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5644,"price":2.58,"value":14561.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":99356,"source":{"system":"sec-edgar","filing":"0001193125-25-258664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000119312525258664/ownership.xml","form_type":"4"}},{"id":1011457,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-30T16:30:04.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001193125-25-258664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000119312525258664/ownership.xml","form_type":"4"}},{"id":1024011,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:14:17.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":5349,"price":2.15,"value":11500.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025."}],"balance_after":140574,"source":{"system":"sec-edgar","filing":"0001470831-25-000250","document":"wk-form4_1759522454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083125000250/wk-form4_1759522454.xml","form_type":"4"}},{"id":1024010,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:13:58.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":6740,"price":2.15,"value":14491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025."}],"balance_after":58629,"source":{"system":"sec-edgar","filing":"0001470831-25-000249","document":"wk-form4_1759522434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083125000249/wk-form4_1759522434.xml","form_type":"4"}},{"id":1035714,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-19T16:13:49.000Z","date":"2025-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":3.32,"value":9213.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":162342,"source":{"system":"sec-edgar","filing":"0001470831-25-000223","document":"wk-form4_1758312827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083125000223/wk-form4_1758312827.xml","form_type":"4"}},{"id":1035713,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-19T16:13:49.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023."}],"balance_after":165117,"source":{"system":"sec-edgar","filing":"0001470831-25-000223","document":"wk-form4_1758312827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083125000223/wk-form4_1758312827.xml","form_type":"4"}},{"id":1087235,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-15T13:00:15.000Z","date":"2025-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7382,"price":1.99,"value":14690.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":166382,"source":{"system":"sec-edgar","filing":"0001662579-25-000057","document":"wk-form4a_1752584408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000057/wk-form4a_1752584408.xml","form_type":"4/A","original_submission_date":"2025-07-14"}},{"id":1087234,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-15T13:00:15.000Z","date":"2025-07-10","kind":"exercise","planned":false,"acquired":true,"shares":15325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in  Table I of the Form 4 filed by the Reporting Person on July 12, 2023."}],"balance_after":173764,"source":{"system":"sec-edgar","filing":"0001662579-25-000057","document":"wk-form4a_1752584408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000057/wk-form4a_1752584408.xml","form_type":"4/A","original_submission_date":"2025-07-14"}},{"id":1087901,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-14T20:19:30.000Z","date":"2025-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7382,"price":1.99,"value":14690.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":166382,"source":{"system":"sec-edgar","filing":"0001662579-25-000055","document":"wk-form4_1752524362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000055/wk-form4_1752524362.xml","form_type":"4"}},{"id":1094157,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:17:16.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":7616,"price":1.51,"value":11500.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025."}],"balance_after":135225,"source":{"system":"sec-edgar","filing":"0001662579-25-000053","document":"wk-form4_1751487429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000053/wk-form4_1751487429.xml","form_type":"4"}},{"id":1094156,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:17:06.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":9609,"price":1.51,"value":14509.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025."}],"balance_after":51889,"source":{"system":"sec-edgar","filing":"0001662579-25-000052","document":"wk-form4_1751487418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000052/wk-form4_1751487418.xml","form_type":"4"}},{"id":1104575,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35088,"kind":"person","name":"Koppikar Utpal","position":1,"cik":"0001742696","reported_name":"Koppikar Utpal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:12:00.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000049","document":"wk-form4_1750450313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000049/wk-form4_1750450313.xml","form_type":"4"}},{"id":1104987,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:50.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000048","document":"wk-form4_1750450303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000166257925000048/wk-form4_1750450303.xml","form_type":"4"}},{"id":1105238,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35222,"kind":"person","name":"Fawell Stephen","position":1,"cik":"0002033387","reported_name":"Fawell Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:39.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000047","document":"wk-form4_1750450293.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033387/000166257925000047/wk-form4_1750450293.xml","form_type":"4"}},{"id":1104574,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:29.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000046","document":"wk-form4_1750450283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000046/wk-form4_1750450283.xml","form_type":"4"}},{"id":1104573,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35086,"kind":"person","name":"Bessen Laura","position":1,"cik":"0001926815","reported_name":"Bessen Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:21.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000045","document":"wk-form4_1750450270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000045/wk-form4_1750450270.xml","form_type":"4"}},{"id":1104572,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:07.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000044","document":"wk-form4_1750450260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000044/wk-form4_1750450260.xml","form_type":"4"}},{"id":1104571,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35087,"kind":"person","name":"Cooper Ronald Harold Wilfred","position":1,"cik":"0001676880","reported_name":"Cooper Ronald Harold Wilfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:10:56.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000043","document":"wk-form4_1750450250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000043/wk-form4_1750450250.xml","form_type":"4"}},{"id":1104656,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":26666,"kind":"person","name":"Hoerter Steven L.","position":1,"cik":"0001533451","reported_name":"Hoerter Steven L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:10:47.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000042","document":"wk-form4_1750450241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533451/000166257925000042/wk-form4_1750450241.xml","form_type":"4"}},{"id":1178700,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32614,"kind":"person","name":"GROGAN DONNA ROY","position":1,"cik":"0001788455","reported_name":"GROGAN DONNA ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:11:53.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":9581,"price":1.435,"value":13748.735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025."}],"balance_after":42280,"source":{"system":"sec-edgar","filing":"0001662579-25-000025","document":"wk-form4_1743711105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000025/wk-form4_1743711105.xml","form_type":"4"}},{"id":1178699,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:11:41.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7841,"price":1.435,"value":11251.835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025."}],"balance_after":127609,"source":{"system":"sec-edgar","filing":"0001662579-25-000024","document":"wk-form4_1743711094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000024/wk-form4_1743711094.xml","form_type":"4"}},{"id":1263278,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:55:35.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":335300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":335300,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":335300},"source":{"system":"sec-edgar","filing":"0001662579-25-000021","document":"wk-form4_1739915729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000166257925000021/wk-form4_1739915729.xml","form_type":"4"}},{"id":1263277,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:35.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9370,"price":3.18,"value":29796.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":423145,"source":{"system":"sec-edgar","filing":"0001662579-25-000021","document":"wk-form4_1739915729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000166257925000021/wk-form4_1739915729.xml","form_type":"4"}},{"id":1263276,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:35.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":12847,"price":3.18,"value":40853.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":432515,"source":{"system":"sec-edgar","filing":"0001662579-25-000021","document":"wk-form4_1739915729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000166257925000021/wk-form4_1739915729.xml","form_type":"4"}},{"id":1263275,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":36225,"kind":"person","name":"Hirsch Andrew","position":1,"cik":"0001586707","reported_name":"Hirsch Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:35.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":223500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":445362,"source":{"system":"sec-edgar","filing":"0001662579-25-000021","document":"wk-form4_1739915729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586707/000166257925000021/wk-form4_1739915729.xml","form_type":"4"}},{"id":1263240,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":49049,"kind":"person","name":"Siegel Jolie","position":1,"cik":"0001768223","reported_name":"Siegel Jolie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:55:25.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":84700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":84700,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":84700},"source":{"system":"sec-edgar","filing":"0001662579-25-000020","document":"wk-form4_1739915720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000020/wk-form4_1739915720.xml","form_type":"4"}},{"id":1263239,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":49049,"kind":"person","name":"Siegel Jolie","position":1,"cik":"0001768223","reported_name":"Siegel Jolie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:25.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2914,"price":3.18,"value":9266.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":107939,"source":{"system":"sec-edgar","filing":"0001662579-25-000020","document":"wk-form4_1739915720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000020/wk-form4_1739915720.xml","form_type":"4"}},{"id":1263238,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":49049,"kind":"person","name":"Siegel Jolie","position":1,"cik":"0001768223","reported_name":"Siegel Jolie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:25.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":110853,"source":{"system":"sec-edgar","filing":"0001662579-25-000020","document":"wk-form4_1739915720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000020/wk-form4_1739915720.xml","form_type":"4"}},{"id":1263237,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":49049,"kind":"person","name":"Siegel Jolie","position":1,"cik":"0001768223","reported_name":"Siegel Jolie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:25.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2135,"price":3.2,"value":6832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":54353,"source":{"system":"sec-edgar","filing":"0001662579-25-000020","document":"wk-form4_1739915720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000020/wk-form4_1739915720.xml","form_type":"4"}},{"id":1264275,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65931,"kind":"person","name":"Mossler Mark","position":1,"cik":"0001992219","reported_name":"Mossler Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:55:06.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1586,"price":3.18,"value":5043.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":18204,"source":{"system":"sec-edgar","filing":"0001662579-25-000018","document":"wk-form4_1739915700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992219/000166257925000018/wk-form4_1739915700.xml","form_type":"4"}},{"id":1263225,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:54:57.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":84700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":84700,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":84700},"source":{"system":"sec-edgar","filing":"0001662579-25-000017","document":"wk-form4_1739915691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000017/wk-form4_1739915691.xml","form_type":"4"}},{"id":1263224,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:57.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2368,"price":3.18,"value":7530.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":108885,"source":{"system":"sec-edgar","filing":"0001662579-25-000017","document":"wk-form4_1739915691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000017/wk-form4_1739915691.xml","form_type":"4"}},{"id":1263223,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:57.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":111253,"source":{"system":"sec-edgar","filing":"0001662579-25-000017","document":"wk-form4_1739915691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000017/wk-form4_1739915691.xml","form_type":"4"}},{"id":1263222,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65841,"kind":"person","name":"Schick Kelly","position":1,"cik":"0001797388","reported_name":"Schick Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:57.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1735,"price":3.2,"value":5552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":54753,"source":{"system":"sec-edgar","filing":"0001662579-25-000017","document":"wk-form4_1739915691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000017/wk-form4_1739915691.xml","form_type":"4"}},{"id":1263308,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":130600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":130600,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":130600},"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1263307,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5145,"price":3.18,"value":16361.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":173764,"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1263306,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":87100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":178909,"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1265048,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-14","kind":"grant","planned":true,"acquired":true,"shares":84700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":84700,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":84700},"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1265047,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":669,"price":3.15,"value":2107.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024."}],"balance_after":107805,"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1265046,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-14","kind":"tax_withholding","planned":true,"acquired":false,"shares":2368,"price":3.18,"value":7530.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":108474,"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1265045,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":490,"price":3.15,"value":1543.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024."}],"balance_after":110842,"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1265044,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-14","kind":"grant","planned":true,"acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":111332,"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1265043,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":66004,"kind":"person","name":"Boyle Scott N","position":1,"cik":"0001913897","reported_name":"Boyle Scott N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:55:16.000Z","date":"2025-02-13","kind":"tax_withholding","planned":true,"acquired":false,"shares":1735,"price":3.2,"value":5552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":54832,"source":{"system":"sec-edgar","filing":"0001662579-25-000019","document":"wk-form4_1739915710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913897/000166257925000019/wk-form4_1739915710.xml","form_type":"4"}},{"id":1264269,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":130600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":130600,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":130600},"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264268,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4559,"price":3.18,"value":14497.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":165117,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264267,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":87100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":169676,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264266,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1863,"price":3.2,"value":5961.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":82576,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264398,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T16:54:38.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":42400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":42400,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001662579-25-000015","document":"wk-form4_1739915672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000166257925000015/wk-form4_1739915672.xml","form_type":"4"}}],"next_cursor":"2025-02-18T16:54:38.000000Z,1264398"}